Enbridge Inc
ENB
TC Energy Corp
TRP
Power Corporation of Canada
POW
Emera Inc
EMA
The Toronto-Dominion Bank
TD
CA Stock MarketDetailed Quotes
WEED Canopy Growth Corp
- 2.030
- 0.0000.00%
15min DelayMarket Closed Feb 28 16:00 ET
298.65MMarket Cap-0.42P/E (TTM)
2.050High1.970Low833.39KVolume2.010Open2.030Pre Close1.67MTurnover20.50052wk High0.57%Turnover Ratio147.12MShares1.97052wk Low-4.8EPS TTM298.51MFloat Cap766.800Historical HighLossP/E (Static)147.05MShs Float0.250Historical Low-8.79EPS LYR3.94%Amplitude--Dividend TTM0.50P/B1Lot Size--Div YieldTTM
Canopy Growth Corp News
Analysts Offer Insights on Healthcare Companies: Ansell (OtherANSLF) and Canopy Growth (CGC)
Analysts' Opinions Are Mixed on These Healthcare Stocks: Canopy Growth (CGC), Medtronic (MDT) and Teladoc (TDOC)
BofA Securities Maintains Canopy Growth(CGC.US) With Sell Rating, Cuts Target Price to $1.4
Roth MKM Initiates Canopy Growth(CGC.US) With Buy Rating, Announces Target Price $6.99
CCORF Downgrades Canopy Growth(CGC.US) to Sell Rating, Cuts Target Price to $1.05
Canopy Growth Corp. Price Target Cut to C$3.20/Share From C$4.00 by ATB Capital
Canopy Growth Corp. Is Maintained at Underperform by ATB Capital
A. G. P. Maintains Canopy Growth(CGC.US) With Hold Rating, Cuts Target Price to $2.8
ATB Capital Markets Downgrades Canopy Growth(CGC.US) to Sell Rating, Cuts Target Price to $2.79
Canopy Growth (CGC) Was Downgraded to a Sell Rating at ATB Capital Markets
Canopy Growth Corp Price Target Cut to C$4.00/Share From C$6.00 by ATB Capital
Canopy Growth Corp. Price Target Cut to C$3.50/Share From C$5.00 by Canaccord Genuity
Analysts Offer Insights on Healthcare Companies: Novavax (NVAX), Regulus (RGLS) and Canopy Growth (CGC)
Piper Sandler Reaffirms Their Sell Rating on Canopy Growth (CGC)
Canopy Gwth Analyst Ratings
Piper Sandler Maintains Canopy Growth at Underweight, Cuts Price Target to US$2.00 on Weak Sales
Analysts Conflicted on These Healthcare Names: Cooper Co (COO), Canopy Growth (CGC) and BioMarin Pharmaceutical (BMRN)
Analysts Conflicted on These Healthcare Names: Canopy Growth (CGC), Ultragenyx Pharmaceutical (RARE) and Roivant Sciences (ROIV)
Canopy Growth Sell Rating Justified by Stagnant Sales, High Valuation, and Profitability Concerns
Canopy Growth's (TSE:WEED) US Invasion Falls Flat With Shareholders
Trending Stocks
Dividend Kings of Canada Dividend Kings of Canada
Dividend Kings In Canada are companies that have increased their Dividend per share for the most consecutive years, reflecting a strong business model and robust financials, and are likely to outperform the market with less volatility. Dividend Kings In Canada are companies that have increased their Dividend per share for the most consecutive years, reflecting a strong business model and robust financials, and are likely to outperform the market with less volatility.
